Literature DB >> 16648103

Damage assessment in gastric cancer treatment with adjuvant radiochemotherapy: calculation of the NTCP's from the differential HDV of the organs at risk.

Amadeo Wals1, Jorge Contreras, José Macías, Inmaculada Fortes, Daniel Rivas, Pedro González, Ismael Herruzo.   

Abstract

OBJECTIVE: To calculate the Normal Tissue Complication Probabilities (NTCP) for the liver, right kidney, left kidney and spinal cord, as well as the global Uncomplicated Tumour Control Probability (UTCP) in gastric cancer patients who underwent a treatment with radiotherapy after radical surgery in our environment. MATERIAL AND
METHOD: In April 2000, a postoperative chemotherapy (QT-RT) protocol started in the province of Malaga for Gastric Adenocarcinomas with postsurgical stage II or higher (pT3-4 and/or pN+). This clinical protocol served as a base for our NTCP and UTCP retrospective theorical study. A virtual simulation and a 3D planning were made in all cases. The differential HDV, selected for each patient were obtained for the 4 organs at risk (OR). Hystograms reduction was made by the Kutcher and Burman's Effective Volume method. NTCP calculations by Lyman's models. The following variables were calculated: maximal dose for each organ (Dmax), Effective Volume (Veff), TD50 (Veff/Vref); NTCP for each organ of the patient; global UTCP for each patient. Differences between the 2 treatment techniques were analysed (2-field versus 4-field technique). For the NTCP calculations the computer application Albireo 1.0(R) was used.
RESULTS: 29 patients to assess with an average age of 54 +/- 10 years (range: 38-71); 65.5% men/34.5% women. The technique used was the field technique AP-PA in the 51.7% (15) and with 4 fields in 48.3% (14) of the cases. The global damage is estimated in 16% with a range between 0 and 37%. This goes up to 25% with the 2-field technique, with a wide range between 2 and 48% and it remains reduced to 4%, within a range between 0 and 12% when 4 fields are used. There were significant differences concerning the estimated damage probability (NTCP) on liver, spinal cord and left kidney, depending on the use of two or four fields.
CONCLUSION: NTCP and the global UTCP values of the organs at risk allow to compare a technique net benefit from another in each particular case, although in our theoretical study the comparison was done among the patients. It is important to stress that the calculations of the TCP and NTCP have a limited quantitative signification but they are useful and beneficial in order to decide between treatment plans when they are supported by the clinical knowledge.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648103     DOI: 10.1007/BF02664938

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  12 in total

1.  Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization.

Authors:  M Zaider; H I Amols
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-05-01       Impact factor: 7.038

2.  Fitting of normal tissue tolerance data to an analytic function.

Authors:  C Burman; G J Kutcher; B Emami; M Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

Review 3.  Tolerance of normal tissue to therapeutic irradiation.

Authors:  B Emami; J Lyman; A Brown; L Coia; M Goitein; J E Munzenrider; B Shank; L J Solin; M Wesson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

4.  Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.

Authors:  G J Kutcher; C Burman; L Brewster; M Goitein; R Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

Review 5.  A systematic overview of chemotherapy effects in gastric cancer.

Authors:  K G Janunger; L Hafström; P Nygren; B Glimelius
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

6.  Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients.

Authors:  Z X Zhang; X Z Gu; W B Yin; G J Huang; D W Zhang; R G Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-12-01       Impact factor: 7.038

7.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

Authors:  G J Kutcher; C Burman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

8.  Complication probability as assessed from dose-volume histograms.

Authors:  J T Lyman
Journal:  Radiat Res Suppl       Date:  1985

9.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

10.  Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation.

Authors:  Stephen R Smalley; Leonard Gunderson; Joel Tepper; James A Martenson; Bruce Minsky; Christopher Willett; Tyvin Rich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

View more
  2 in total

1.  Usefulness of chemoradiotherapy for inoperable gastric cancer.

Authors:  T Taki; Y Hoya; A Watanabe; T Nakayoshi; T Okamoto; H Sekine; N Mitsumori; K Yanaga
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

2.  Exposure-response modeling improves selection of radiation and radiosensitizer combinations.

Authors:  Tim Cardilin; Joachim Almquist; Mats Jirstrand; Astrid Zimmermann; Floriane Lignet; Samer El Bawab; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-08       Impact factor: 2.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.